• Login
    • Join
  • FOLLOW:
  • Subscribe Free
    • Magazine
    • eNewsletter
    Checkout
    • Magazine
    • News
    • Exclusives
    • Nutraceuticals
    • Markets
    • Health
    • Jobs
    • Events
    • Buyers' Guide
    • Showcases
    • More
  • Magazine
  • News
  • Exclusives
  • Nutraceuticals
  • Markets
  • Health
  • Jobs
  • Events
  • Buyers' Guide
  • Showcases
  • Current & Past Issues
    Features
    Columns
    Editorials
    Digital Edition
    Subscribe Now
    Advertise Now
    eNewsletter
    Editorial Guidelines
    Top Features
    A Kingdom of Their Own: Fungi Shine While Mushrooms Emerge as Market Stars

    Functional Beverage Market Shakes Things Up with Formulation Breakthroughs

    The Pet Health Boom: Supplement Growth Set to Build on Rapid Expansion

    (Re)Open for Business: China’s Strong Demand for Natural Products Spells Opportunity for U.S. Brands

    Review Finds No Causative Connection Between Dietary Supplements and Eating Disorders
    Breaking News
    Certifications, Approvals and Patents
    Exclusives
    Industry & Market News
    People
    Products
    Regulatory
    Glossary
    Research
    Supplier News
    Supplier Insights
    Live From Shows
    Top News
    SmartyPants Vitamins Launches New Line of Gelatin-Free Multivitamin Gummies

    Flavanol Deficiency Linked to Age-Related Memory Decline: COSMOS-Web Study

    AHPA to Attend CITES Plants Committee Meeting in Geneva

    NY General Assembly Passes Bill to Restrict Sales of Weight Loss Supplements

    Stefan Pasiakos, PhD, Selected to Lead NIH Office of Dietary Supplements
    Exclusives
    Blogs & Guest Articles
    Health E-Insights
    Area Code 420
    eBook
    Antioxidants
    Dairy-Based Ingredients
    Enzymes
    Fatty Acids
    Fiber & Carbohydrates
    Green Foods
    Herbs & Botanicals
    Marine Nutraceuticals
    Minerals
    Omega 3s
    Probiotics & Prebiotics
    Proteins, Peptides, Amino Acids
    Sweeteners
    Vitamins

    SmartyPants Vitamins Launches New Line of Gelatin-Free Multivitamin Gummies

    Flavanol Deficiency Linked to Age-Related Memory Decline: COSMOS-Web Study

    AHPA to Attend CITES Plants Committee Meeting in Geneva

    Shroom(rise) Kingdom

    Improving Taste and Mouthfeel of Plant-Based Protein Formulations
    Consumer Trends
    Contract Manufacturing
    Cosmeceuticals / Nutricosmetics
    Delivery & Dosage Technologies
    Dietary Supplements
    Flavors & Colors
    Functional Foods & Beverages
    Healthcare Trends
    Medical Nutrition
    Mergers & Acquisitions
    Natural/Organic
    Nutrition Bars
    Packaging
    Pet Nutraceuticals
    Quality & Safety
    Regulations
    Research
    Testing
    World Markets

    SmartyPants Vitamins Launches New Line of Gelatin-Free Multivitamin Gummies

    Flavanol Deficiency Linked to Age-Related Memory Decline: COSMOS-Web Study

    AHPA to Attend CITES Plants Committee Meeting in Geneva

    NY General Assembly Passes Bill to Restrict Sales of Weight Loss Supplements

    Shroom(rise) Kingdom
    Bone & Joint Health
    Cancer Risk
    Cardiovascular Health
    Cognitive Function
    Diabetes & Blood Sugar Management
    Digestive Health
    Energy
    Eye Health
    Healthy Aging
    Immune Function
    Infant & Children's Health
    Inflammation
    Men's Health
    Mood Health & Sleep
    Oral Health
    Sexual & Reproductive Health
    Skin Health
    Sports Nutrition
    Weight Management/Weight Loss
    Women's Health

    Flavanol Deficiency Linked to Age-Related Memory Decline: COSMOS-Web Study

    NY General Assembly Passes Bill to Restrict Sales of Weight Loss Supplements

    Functional Beverage Market Shakes Things Up with Formulation Breakthroughs

    A Kingdom of Their Own: Fungi Shine While Mushrooms Emerge as Market Stars

    ‘Uniquely Unbound’: Releasing the Potential, and Genius, of Walnuts
    Industry Events
    Live From Show Events
    Webinars
    All Companies
    Categories
    Trade Associations
    Company Capabilities
    International Buyers Guide Companies
    Xsto Solutions

    PhytoGaia Inc

    Gencor

    Verdure Sciences

    Premium Labels & Packaging Solutions
    Companies
    Product Releases
    News Releases
    Literature / Brochures
    White Papers
    Jobs
    VIdeos
    Services
    Add New Company
    International Buyers Guide Companies
    Xsto Solutions

    PhytoGaia Inc

    Gencor

    Verdure Sciences

    Premium Labels & Packaging Solutions
    • Magazine
      • Current / Back Issue
      • Features
      • Editorial
      • Columns
      • Digital Edition
      • eNewsletter Archive
      • Editorial Guidelines
      • Subscribe Now
      • Advertise Now
    • Breaking News
    • Buyers' Guide
      • All Companies
      • Categories
      • Trade Associations
      • Company Capabilities
    • Nutraceuticals
      • Antioxidants
      • Dairy-Based Ingredients
      • Enzymes
      • Fatty Acids
      • Fiber & Carbohydrates
      • Green Foods
      • Herbs & Botanicals
      • Marine Nutraceuticals
      • Minerals
      • Omega 3s
      • Probiotics & Prebiotics
      • Proteins, Peptides, Amino Acids
      • Sweeteners
      • Vitamins
    • Markets
      • Consumer Trends
      • Contract Manufacturing
      • Cosmeceuticals / Nutricosmetics
      • Delivery & Dosage Technologies
      • Dietary Supplements
      • Flavors & Colors
      • Functional Foods & Beverages
      • Healthcare Trends
      • Medical Nutrition
      • Mergers & Acquisitions
      • Natural/Organic
      • Nutrition Bars
      • Packaging
      • Pet Nutraceuticals
      • Quality & Safety
      • Regulations
      • Research
      • Testing
      • World Markets
    • Health
      • Bone & Joint Health
      • Cancer Risk
      • Cardiovascular Health
      • Cognitive Function
      • Diabetes & Blood Sugar Management
      • Digestive Health
      • Energy
      • Eye Health
      • Healthy Aging
      • Immune Function
      • Infant & Children's Health
      • Inflammation
      • Men's Health
      • Mood Health & Sleep
      • Oral Health
      • Sexual & Reproductive Health
      • Skin Health
      • Sports Nutrition
      • Weight Management/Weight Loss
      • Women's Health
    • Online Exclusives
    • Webinars
    • Slideshows
    • Blogs & Guest Articles
    • Health E-Insights
    • Videos
    • Podcasts
    • Infographics
    • eBook
    • Whitepapers
    • Research
      • TrendSense
      • Monograph Center
      • White Papers
      • Research News
    • Jobs
    • Events
      • Industry Events
      • Live From Show Events
      • Webinars
    • Supplier Showcases
      • Companies
      • Product Releases
      • News Releases
      • Literature / Brochures
      • White Papers
      • Jobs
      • VIdeos
      • Services
    • About Us
      • About Us
      • Contact Us
      • Advertise With Us
      • Privacy Policy
      • Terms of Use
    Breaking News

    Study Demonstrates Safety of Sustained Niagen Supplementation & Optimal Dose

    Data will be used to design trials that test the activity of Niagen against diseases and conditions of metabolic stress.

    Study Demonstrates Safety of Sustained Niagen Supplementation & Optimal Dose
    07.08.19
    The largest clinical trial to date on nicotinamide riboside (NR), according to ChromaDex Corp., further validated the safety and efficacy of the company’s proprietary form of NR, Niagen. Results were was published in the journal Scientific Reports.
     
    “The results of this large human trial directly support the efficacy and safety of our NAD-boosting consumer product Tru Niagen,” said ChromaDex CEO Rob Fried. “The study also provides key data points for regulatory submissions as we continue our global expansion.”
     
    This is the first clinical trial to measure both the kinetics and dose-dependent effects of chronic Niagen supplementation, according to the company; 132 healthy overweight adults completed the randomized, double-blind, placebo-controlled, parallel arm trial. The results showed how supplementation with three different daily doses of Niagen (100 mg, 300 mg, 1,000 mg) initially increase and then sustain elevated blood NAD levels over the course of an 8-week period.
     
    The results of this study support the NAD-boosting efficacy of Tru Niagen, which recommends a daily serving size of 300 mg in the U.S. On average, study participants consuming 300 mg/day experienced a statistically significant 51% increase in whole blood NAD+ within two weeks. This increase was maintained throughout the remainder of the eight-week study.
     
    The study also joins previous chronic supplementation studies to support the safety of chronic Niagen supplementation. All doses tested were well-tolerated with no attributable adverse events reported. By the end of the eight-week trial, no changes in LDL cholesterol levels or blood levels of homocysteine were observed. These results further differentiate Niagen from other NAD-boosting supplements and support the establishment of a unique upper limit for Niagen versus other B3 vitamins, the company said.
     
    “This is a timely publication in the history of Niagen as it clearly shows safe, dose-dependent and time-dependent increases in blood NAD in human populations,” said Charles Brenner, PhD, Roy J. Carver Chair & Head of Biochemistry at the University of Iowa & ChromaDex chief scientific advisor. “With so much global interest in NAD-boosting supplementation strategies, our approach to human translation has been to put safety first. These data will be used to design the next generation of trials to promote wellness as well as to test the activity of Niagen against diseases and conditions of metabolic stress.”
     
    “This clinical study builds upon a body of research demonstrating the safe and sustained benefits of Niagen supplementation, and importantly identifies optimal dosing to achieve increased NAD levels over time,” said Matthew Roberts, PhD, chief scientific officer, ChromaDex. 
     
    To date, ChromaDex has invested millions of dollars in safety and human clinical trials on its patent-protected NR (commercially known as Niagen) and has entered research agreements with more than 160 institutions for research, including Dartmouth, the National Institutes of Health, University of Iowa, and the Scripps Research Institute.
     
    NIAGEN is the only commercially available nicotinamide riboside which has twice been reviewed under FDA's new dietary ingredient (NDI) notification program and has also been successfully notified to the FDA as generally recognized as safe (GRAS).
    Related Searches
    • Stress
    • GRAS
    • Research
    • vitamins
    Related Knowledge Center
    • Research
    • Vitamins
    • Healthy Aging
    Suggested For You
    EAS Assists Food & Hemp Firms with GRAS Submissions EAS Assists Food & Hemp Firms with GRAS Submissions
    Preparing for FDA’s New Era of Food Safety Preparing for FDA’s New Era of Food Safety
    Engaging Doctors in the Dialogue About ‘DSHEA 2.0’ Engaging Doctors in the Dialogue About ‘DSHEA 2.0’
    Partnership to Help Improve GMP Compliance, GRAS & NDI Application Process Partnership to Help Improve GMP Compliance, GRAS & NDI Application Process
    Nicotinamide Riboside Linked to Cardiovascular Benefits Nicotinamide Riboside Linked to Cardiovascular Benefits
    FDA Launches Dietary Supplement Ingredient Advisory List FDA Launches Dietary Supplement Ingredient Advisory List
    FDA to Hold Public Meeting on ‘Responsible Innovation in Dietary Supplements’ FDA to Hold Public Meeting on ‘Responsible Innovation in Dietary Supplements’
    FDA Commissioner Scott Gottlieb to Resign FDA Commissioner Scott Gottlieb to Resign
    FDA to Hold Meeting on Regulatory Status of CBD in April FDA to Hold Meeting on Regulatory Status of CBD in April
    FDA Plans to Modernize Dietary Supplement Regulations FDA Plans to Modernize Dietary Supplement Regulations
    Study: NR During Breastfeeding Yields Lasting Benefits to Mothers and Offspring in Animal Model Study: NR During Breastfeeding Yields Lasting Benefits to Mothers and Offspring in Animal Model
    2018 Farm Bill Brings Victory for Hemp, Uncertainty for CBD 2018 Farm Bill Brings Victory for Hemp, Uncertainty for CBD
    ChromaDex ChromaDex

    Related Breaking News

    • Breaking News | Industry & Market News | Quality & Safety

      EAS Assists Food & Hemp Firms with GRAS Submissions

      Firm provides comprehensive services through all phases of the technical GRAS or self-GRAS filing process.
      06.07.19

    • Preparing for FDA’s New Era of Food Safety

      Preparing for FDA’s New Era of Food Safety

      Here are some insights into U.S. regulatory requirements regarding the safety of food and dietary supplements.
      By Gregory Stephens, Windrose Partners, & Sanford W. Bigelow, Vanguard Global Associates LLC 06.03.19

    • Dietary Supplements | Healthcare Trends | Medical Nutrition | Regulations
      Engaging Doctors in the Dialogue About ‘DSHEA 2.0’

      Engaging Doctors in the Dialogue About ‘DSHEA 2.0’

      The need for clear and truthful clinical communication should be on the table for discussion as DSHEA goes under review.
      By Erik Goldman, Holistic Primary Care 05.02.19


    • Breaking News | Dietary Supplements | Industry & Market News | Quality & Safety | Regulations | Testing

      Partnership to Help Improve GMP Compliance, GRAS & NDI Application Process

      Alkemist Labs and REJIMUS to help companies fulfill regulatory obligations.
      04.22.19

    • Breaking News | Cardiovascular Health | Research | Research News | Supplier News | Vitamins
      Nicotinamide Riboside Linked to Cardiovascular Benefits

      Nicotinamide Riboside Linked to Cardiovascular Benefits

      The novel form of vitamin B3 helped maintain mitochondrial function in an animal model by stimulating a cellular repair pathway.
      04.17.19

    Loading, Please Wait..
    Trending
    • Soviets Took Probiotics To The Next Level
    Breaking News
    • SmartyPants Vitamins Launches New Line of Gelatin-Free Multivitamin Gummies
    • Flavanol Deficiency Linked to Age-Related Memory Decline: COSMOS-Web Study
    • AHPA to Attend CITES Plants Committee Meeting in Geneva
    • NY General Assembly Passes Bill to Restrict Sales of Weight Loss Supplements
    • Stefan Pasiakos, PhD, Selected to Lead NIH Office of Dietary Supplements
    View Breaking News >
    CURRENT ISSUE

    June 2023

    • Functional Beverage Market Shakes Things Up with Formulation Breakthroughs
    • A Kingdom of Their Own: Fungi Shine While Mushrooms Emerge as Market Stars
    • The Pet Health Boom: Supplement Growth Set to Build on Rapid Expansion
    • (Re)Open for Business: China’s Strong Demand for Natural Products Spells Opportunity for U.S. Brands
    • Review Finds No Causative Connection Between Dietary Supplements and Eating Disorders
    • KA! Empathogenics: Creating Calm and Connectedness with Inspiration from Nature
    • View More >

    Cookies help us to provide you with an excellent service. By using our website, you declare yourself in agreement with our use of cookies.
    You can obtain detailed information about the use of cookies on our website by clicking on "More information”.

    • About Us
    • Privacy Policy
    • Terms And Conditions
    • Contact Us

    follow us

    Subscribe
    Nutraceuticals World

    Latest Breaking News From Nutraceuticals World

    SmartyPants Vitamins Launches New Line of Gelatin-Free Multivitamin Gummies
    Flavanol Deficiency Linked to Age-Related Memory Decline: COSMOS-Web Study
    AHPA to Attend CITES Plants Committee Meeting in Geneva
    Coatings World

    Latest Breaking News From Coatings World

    PPG Opens $30-Million Battery Pack Application Center in China
    Fact.MR: Steel Pipe Coatings Market To Hit $14.0 Billion By 2033
    Omya Extends Lightweight Fillers Portfolio with the Acquisition of Bublon
    Medical Product Outsourcing

    Latest Breaking News From Medical Product Outsourcing

    Microbot receives Grant for Endovascular Surgical Robot System
    Recall of Abiomed's Impella 5.5 with SmartAssist is Class I
    New FDA Nod Boosts Philips, Masimo Partnership
    Contract Pharma

    Latest Breaking News From Contract Pharma

    KBI Biopharma Unveils KBI PUREplatform
    AGC Biologics Introduces AGCellerate to Deliver IND-Ready GMP Material
    Element Creates New Lab Solutions Division
    Beauty Packaging

    Latest Breaking News From Beauty Packaging

    Fasten Wins Gold at German Innovation Awards
    Attitude Expands Oceanly Makeup Collection
    L'Oréal Leads Funding Round for Biotech Company, Debut
    Happi

    Latest Breaking News From Happi

    Skylar’s ‘Boardwalk Delight’ Eau de Parfum Launches to Record Success at Sephora
    Register for the IBA Cocktail Reception in Las Vegas During Cosmoprof North America
    Amyris Announces Transformation Program
    Ink World

    Latest Breaking News From Ink World

    DuPont Artistri Inks Expands Pigment Inks Portfolio at ITMA 2023
    Toyochem Constructs New Pilot Facility for High-Performance Polymers
    UFlex Reports Unaudited 4Q, Full Year 2023 Results
    Label & Narrow Web

    Latest Breaking News From Label & Narrow Web

    Baldwin to exhibit 'Complete Quality Control Solutions' at High Security Printing Latin America
    Label Source acquires division of OMNI Systems
    Vetaphone demos ‘M’ corona treater at Mark Andy showroom
    Nonwovens Industry

    Latest Breaking News From Nonwovens Industry

    Maxcess International Opens New Facility in Mumbai
    emtec Showcases Groundbreaking Achievement in Haptic Measurement
    Hollingworth & Vose Joins United Nations Global Compact initiative
    Orthopedic Design & Technology

    Latest Breaking News From Orthopedic Design & Technology

    Orthonika Receives Grant for Total Meniscus Replacement
    Treace to Buy RPM-3D Tech for Up to $30 Million
    Former BD, J&J Executives Join Acuitive Technologies Board
    Printed Electronics Now

    Latest Breaking News From Printed Electronics Now

    Schreiner Group Receives Three FINAT Awards
    MClimate Releases Maintenance-Free CO2 Display
    Blackstone Completes Acquisition of Majority Stake of Copeland

    Copyright © 2023 Rodman Media. All rights reserved. Use of this constitutes acceptance of our privacy policy The material on this site may not be reproduced, distributed, transmitted, or otherwise used, except with the prior written permission of Rodman Media.

    AD BLOCKER DETECTED

    Our website is made possible by displaying online advertisements to our visitors.
    Please consider supporting us by disabling your ad blocker.


    FREE SUBSCRIPTION Already a subscriber? Login